デフォルト表紙
市場調査レポート
商品コード
1233128

放射線腫瘍学の市場規模、シェア、動向分析レポート:タイプ別(外部ビーム放射線療法、内部ビーム放射線療法)、技術別、用途別、地域別、セグメント予測、2023年~2030年

Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Technology, By Application, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 130 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
放射線腫瘍学の市場規模、シェア、動向分析レポート:タイプ別(外部ビーム放射線療法、内部ビーム放射線療法)、技術別、用途別、地域別、セグメント予測、2023年~2030年
出版日: 2023年02月06日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

放射線腫瘍学市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の放射線腫瘍学市場は、2023年から2030年にかけて12.3%のCAGRを記録し、2030年までに211億4000万米ドルに達すると予想されています。

市場の成長は、世界のがん負担の増加、老年人口の増加、政府や民間団体が実施する支援的な償還プログラムなどに起因しています。さらに、放射線治療における技術革新と進歩の増加は、市場成長の好機となります。

世界では、がん患者の増加が示されており、これが放射線腫瘍学市場の成長を促進する主要因となっています。例えば、Globocanによると、2020年には2,000万人以上ががんと診断され、1,000万人ががんで死亡しています。さらに、高齢化社会は、免疫力の低下や併存疾患により、がんのリスクが高く、それにより、老年人口の増加が市場成長をさらに後押ししています。例えば、WHOの推計によると、2020年の世界の老年人口は約10億人であり、2050年には21億人に達すると予想されています。

新規放射線治療技術や集学的治療アプローチの開発のための広範な研究活動は、がんの生存率の向上や予後の良好化につながると期待されています。例えば、2022年12月、エレクタ・ユニティ社は、膵臓腫瘍に対するMR-Linacの使用を実証し、史上初の患者が新しい高度放射線治療の動作管理で治療されました。

同様に、2020年6月、イソレイはシンシナティ大学フィジックスカンパニーと頸部・頭部がん治療に関する調査契約を締結しました。両社は、外科的切除後のセシウム131とともにキイトルーダの有効性を評価する予定です。このような医療用アイソトープをがん治療に使用することで、疾患の複雑さと患者のニーズを理解し、新しい標的特異的放射線治療システムの開発研究が促進され、市場の機会を拡大する可能性があります。

さらに、放射線治療に対する支援的な償還政策や規制政策も、放射線腫瘍学市場の成長を促進すると期待されています。例えば、2021年7月、メディケアおよびメディケイドサービスセンター(CMS)は、がんの診断と放射線治療サービスのための新しい放射線腫瘍学支払いモデル(RO-APM)を開発しました。これにより、患者のケアの質を高め、年間のメディケア支出を削減することができます。

放射線腫瘍学市場レポートハイライト

  • タイプ別では、急速な技術進歩により、様々な種類のがんの治療への導入が進んでいる外部照射療法(EBRT)分野が、2022年の放射線腫瘍学市場で64.53%のシェアを占めています。
  • 技術別に見ると、治療ニーズが満たされていない国々で技術的に高度なIMRTの利用が増加していることから、2022年には強度変調放射線治療(IMRT)分野が市場を独占しました。しかし、ブラキセラピーは予測期間中に最も急速に成長するセグメントとなると推定されます。
  • 2022年、アプリケーション空間では、EBRTセグメントが最も高い市場シェアを占めています。さらに、EBRTセグメントは予測期間中もその優位性を維持すると予測されます。
  • 北米は、新たながん患者の増加、高度な放射線治療に関する医療従事者の高い認識、同地域の医療アクセスの向上などの要因により、2022年の世界市場を独占しました。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • セグメントの範囲
    • 地域範囲
  • 調査手法
  • 情報調達
    • 購入したデータベース:
    • GVRの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査の詳細
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析
      • アプローチ:商品フローアプローチ
  • 二次情報のリスト
  • 略語一覧
  • 目的

第2章 エグゼクティブサマリー

  • 市場概要

第3章 市場変数、動向、範囲

  • 市場セグメンテーション
  • 市場の定義
  • 優先される主要な機会
  • 市場の動的分析
    • 放射線療法の採用の増加
    • 放射線治療における技術の進歩
    • がんの有病率の上昇
    • ヘルスケア費の増加
    • 放射性医薬品のアプリケーションの増加
  • 市場抑制要因分析
    • 熟練した放射線治療専門家の不足
    • 不十分な放射線インフラ
    • 放射線療法の悪影響
  • 事業環境分析
    • SWOT分析;要因別(政治と法律、経済と技術)
    • ポーターのファイブフォース分析

第4章 放射線腫瘍学市場-セグメント分析、タイプ別、2018年から2030年(百万米ドル)

  • 放射線腫瘍学市場:型変動分析
  • 外照射療法
    • 電子放出高エネルギー線形加速器
    • コンパクトな高度放射線治療システム
      • サイバーナイフ
      • ガンマナイフ
      • トモセラピー
    • 陽子線治療
      • サイクロトロン
      • シンクロトロン
  • 内部放射線治療
    • 小線源治療
      • 種子
      • アプリケーターとアフターローダー
      • 電子小線源治療
    • 全身放射線治療
    • その他

第5章 放射線腫瘍学市場-セグメント分析、技術別、2018年から2030年(百万米ドル)

  • 放射線腫瘍学市場:技術変動分析
  • 外照射療法(EBRT)
    • 画像誘導放射線治療(IGRT)
    • 強度変調放射線治療(IMRT)
    • 定位放射線治療
    • 陽子線治療
    • 3D原体放射線治療(3D-CRT)
    • 体積変調アーク療法(VMAT)
  • 小線源治療
    • 低線量率(LDR)小線源治療
    • 高線量率(HDR)小線源治療

第6章 放射線腫瘍学市場-セグメント分析、アプリケーション別、2018年から2030年(百万米ドル)

  • 放射線腫瘍学市場:アプリケーションの変動分析
  • 外照射療法(EBRT)
    • 前立腺がん
    • 乳がん
    • 肺がん
    • 頭頸部がん
    • 大腸がん
    • その他
  • 内部放射線治療
    • 前立腺がん
    • 婦人科がん
    • 乳がん
    • 子宮頸がん
    • 陰茎がん
    • その他

第7章 放射線腫瘍学市場-セグメント分析、地域別、2018年から2030年(百万米ドル)

  • 定義と範囲
  • 北米
    • 北米, SWOT分析
    • 米国
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • カナダ
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
  • 欧州
    • 欧州、 SWOT分析
    • 英国
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • ドイツ
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • フランス
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • イタリア
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • スペイン
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • スウェーデン
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • デンマーク
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • ノルウェー
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • その他欧州
  • アジア太平洋地域
    • アジア太平洋、 SWOT分析
    • インド
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • 中国
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • 日本
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • オーストラリア
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • 韓国
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • タイ
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • APACのその他諸国
  • ラテンアメリカ
    • ラテンアメリカ、 SWOT分析
    • メキシコ
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • ブラジル
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • アルゼンチン
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • 残りのラテンアメリカ
  • MEA
    • 中東・アフリカ、 SWOT分析
    • 南アフリカ
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • サウジアラビア
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • アラブ首長国連邦
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • クウェート
      • 主要な国のダイナミクス
      • 対象疾患の有病率
      • 競合シナリオ
      • 規制の枠組み
      • 償還シナリオ
    • MEAの残り

第8章 競合情勢

  • Public Companies
    • 会社の市況分析
    • 競合ダッシュボード分析
    • 戦略的枠組み
  • Private Companies
    • 主要な新興企業/テクノロジーディスラプター/イノベーターのリスト
    • 地域ネットワークマップ
  • 企業プロファイル
    • Varian Medical Systems, Inc.(A Part Of Siemens Healthineers)
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Elekta AB
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Accuray Incorporated
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Ion Beam Applications(IBA).
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • BD(Becton, Dickinson And Company)
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Isoray Medical
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Mevion Medical Systems
      • 会社概要
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Nordion Inc.
      • 会社概要
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • NTP Radioisotopes SOC Ltd.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Curium
      • 会社概要
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • VIEWRAY TECHNOLOGIES, INC.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 List of Parameters
  • Table 4 List of Distributors
  • Table 5 Global Radiation Oncology Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 Global Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 Global Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 8 Global Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 9 North America Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 North America Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 15 U.S. Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 Canada Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 18 Canada Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 19 Europe Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 22 Europe Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Germany Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 25 Germany Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 U.K. Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 U.K. Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 28 U.K. Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 France Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 30 France Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 31 France Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 Italy Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 33 Italy Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 34 Italy Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Spain Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 Spain Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 37 Spain Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Denmark Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Denmark Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 40 Denmark Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Sweden Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 Sweden Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 43 Sweden Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Norway Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 45 Norway Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 46 Norway Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 Japan Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 Japan Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 53 Japan Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 China Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 China Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 56 China Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 India Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 India Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 59 India Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 South Korea Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 South Korea Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 62 South Korea Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Australia Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 Australia Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 65 Australia Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Thailand Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 67 Thailand Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 68 Thailand Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 Latin America Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 71 Latin America Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 72 Latin America Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 73 Brazil Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 74 Brazil Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 75 Brazil Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Mexico Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 77 Mexico Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 78 Mexico Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 Argentina Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 81 Argentina Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 South Africa Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 90 South Africa Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 91 South Africa Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 UAE Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 UAE Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 94 UAE Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 97 Kuwait Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Radiation oncology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Radiation oncology market snapshot
  • Fig. 10 Radiation oncology market segmentation
  • Fig. 11 Radiation oncology market driver impact
  • Fig. 12 Radiation oncology market restraint impact
  • Fig. 13 Key market opportunities
  • Fig. 14 SWOT analysis, by factor (political & legal economic and technological)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Radiation oncology market: Type outlook and key takeaways
  • Fig. 17 Radiation oncology market: Type movement analysis
  • Fig. 18 External beam radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 19 Electron-emitting high energy linear accelerators market, 2018 - 2030 (USD Million)
  • Fig. 20 Compact advanced radiotherapy systems market, 2018 - 2030 (USD Million)
  • Fig. 21 CyberKnife market, 2018 - 2030 (USD Million)
  • Fig. 22 Gamma Knife market, 2018 - 2030 (USD Million)
  • Fig. 23 Tomotherapy market, 2018 - 2030 (USD Million)
  • Fig. 24 Proton therapy market, 2018 - 2030 (USD Million)
  • Fig. 25 Cyclotron market, 2018 - 2030 (USD Million)
  • Fig. 26 Synchrotron market, 2018 - 2030 (USD Million)
  • Fig. 27 Internal beam radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 28 Brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 29 Seeds market, 2018 - 2030 (USD Million)
  • Fig. 30 Applicators and after-loaders market, 2018 - 2030 (USD Million)
  • Fig. 31 Electronic brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 32 Systemic beam radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 33 Others market, 2016-2028 (USD Million)
  • Fig. 34 Radiation oncology market: External Beam Radiation Therapy (EBRT) technology outlook and key takeaways
  • Fig. 35 Radiation oncology market: External Beam Radiation Therapy (EBRT) technology movement analysis
  • Fig. 36 Radiation oncology market: Internal Beam Radiation Therapy (IBRT) technology movement analysis
  • Fig. 37 EBRT market, 2018 - 2030 (USD Million)
  • Fig. 38 IGRT market, 2018 - 2030 (USD Million)
  • Fig. 39 IMRT market, 2018 - 2030 (USD Million)
  • Fig. 40 Stereotactic radiotherapy market, 2018 - 2030 (USD Million)
  • Fig. 41 Proton beam therapy market, 2018 - 2030 (USD Million)
  • Fig. 42 3D-CRT market, 2018 - 2030 (USD Million)
  • Fig. 43 VMAT market, 2018 - 2030 (USD Million)
  • Fig. 44 Brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 45 LDR brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 46 HDR brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 47 Radiation oncology market: Application outlook and key takeaways
  • Fig. 48 Radiation oncology market: EBRT Application movement analysis
  • Fig. 49 Prostate cancer market, 2018 - 2030 (USD Million)
  • Fig. 50 Breast cancer market, 2018 - 2030 (USD Million)
  • Fig. 51 Lung cancer market, 2018 - 2030 (USD Million)
  • Fig. 52 Head and neck cancer market, 2018 - 2030 (USD Million)
  • Fig. 53 Colorectal cancer market, 2018 - 2030 (USD Million)
  • Fig. 54 Others market, 2018 - 2030 (USD Million)
  • Fig. 55 Prostate cancer market, 2018 - 2030 (USD Million)
  • Fig. 56 Gynecologic cancer market, 2018 - 2030 (USD Million)
  • Fig. 57 Breast cancer market, 2018 - 2030 (USD Million)
  • Fig. 58 Cervical cancer market, 2018 - 2030 (USD Million)
  • Fig. 59 Penile cancer market, 2018 - 2030 (USD Million)
  • Fig. 60 Others market, 2018 - 2030 (USD Million)
  • Fig. 61 Radiation Oncology market: Regional outlook and key takeaways
  • Fig. 62 Radiation Oncology Market: Regional Movement Analysis
  • Fig. 63 North America
  • Fig. 64 North America radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 65 U.S.
  • Fig. 66 U.S. radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 67 Canada
  • Fig. 68 Canada radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 69 Europe
  • Fig. 70 Europe radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 71 Germany
  • Fig. 72 Germany radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 73 U.K.
  • Fig. 74 U.K. radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 75 France
  • Fig. 76 France radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 77 Italy
  • Fig. 78 Italy radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 79 Spain
  • Fig. 80 Spain radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 81 Denmark
  • Fig. 82 Denmark radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 83 Sweden
  • Fig. 84 Sweden radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 85 Norway
  • Fig. 86 Norway radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 87 Rest of Europe
  • Fig. 88 Rest of Europe radiation oncology Market, 2018 - 2030 (USD Million
  • Fig. 89 Asia Pacific
  • Fig. 90 Asia Pacific radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 91 Japan
  • Fig. 92 Japan radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 93 China
  • Fig. 94 China radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 95 India
  • Fig. 96 India radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 97 South Korea
  • Fig. 98 South Korea radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 99 Australia
  • Fig. 100 Australia radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 101 Thailand
  • Fig. 102 Thailand radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 103 Rest of APAC
  • Fig. 104 Rest of APAC radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 105 Latin America
  • Fig. 106 Latin America radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 107 Brazil
  • Fig. 108 Brazil radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 109 Mexico
  • Fig. 110 Mexico radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 111 Argentina
  • Fig. 112 Argentina radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 113 Rest of LATAM
  • Fig. 114 Rest of LATAM radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 115 Middle East & Africa
  • Fig. 116 Middle East and Africa radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 117 South Africa
  • Fig. 118 South Africa radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 119 Saudi Arabia
  • Fig. 120 Saudi Arabia radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 121 UAE
  • Fig. 122 UAE radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 123 Kuwait
  • Fig. 124 Kuwait radiation oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Rest of MEA
  • Fig. 126 Rest of MEA radiation oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Company market share analysis
  • Fig. 128 Company market position analysis (Total revenue)
  • Fig. 129 Company market position analysis (Profit margin)
  • Fig. 130 Competitive dashboard analysis
  • Fig. 131 Regional Network Map
  • Fig. 132 Strategic Framework
目次
Product Code: GVR-1-68038-801-5

Radiation Oncology Market Growth & Trends:

The global radiation oncology market is expected to reach USD 21.14 billion by 2030, registering a CAGR of 12.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the global rise in cancer burden, the growing geriatric population, and supportive reimbursement programs undertaken by the government and private organizations. Furthermore, the increasing technological innovation and advancement in radiotherapy offer lucrative opportunities for market growth.

The world is witnessing an increasing prevalence of cancer cases which is the key factor driving the radiation oncology market growth. For instance, according to Globocan, in 2020, more than 20.0 million people were diagnosed with cancer, and 10.0 million died of cancer. Moreover, the aging population is at high risk of cancer due to a weak immune system and comorbid conditions; thereby, the rising geriatric population further fuels market growth. For instance, in 2020, according to WHO estimates, the global geriatric population was approximately 1.0 billion and is expected to reach 2.1 billion by 2050.

Extensive research activities for the development of novel radiotherapy techniques and multidisciplinary therapeutic approaches are expected to lead to an increased survival rate and a more favorable prognosis of cancer. For instance, in December 2022, Elekta Unity demonstrated MR-Linac use for pancreatic tumors, where the first-ever patient was treated with new advanced radiotherapy motion management.

Similarly, in June 2020, Isoray signed a research agreement with the University of Cincinnati Physicians Company to study neck and head cancer treatment. The companies will evaluate the efficacy of Keytruda along with Cesium-131 post-surgical resection. Using such medical isotopes for cancer treatment may boost the research in developing a new target-specific radiation therapy system by understanding disease complexity & patients' need, thereby widening the opportunity in the market.

Furthermore, supportive reimbursement and regulatory policies for radiation therapy are also expected to drive the radiation oncology market growth. For instance, in July 2021, the Centers for Medicare and Medicaid Services (CMS) developed a new Radiation Oncology Payment Model (RO-APM) for the diagnosis of cancer and radiotherapy services. It enhances the quality of care of the patients and reduces the annual Medicare expenditure.

Radiation Oncology Market Report Highlights:

  • By type, the external beam radiation therapy (EBRT) segment accounted for a 64.53% share of the radiation oncology market in 2022 due to the rapid technological advancement, and increased adoption in the treatment of various types of cancers
  • Based on technology, in 2022 intensity-modulated radiotherapy (IMRT) segment dominated the market due to the increased availability of technologically advanced IMRT's in countries with unmet treatment needs. However, brachytherapy is estimated to be the fastest-growing segment during the forecast period
  • In 2022, EBRT segment held the highest market share in the application space. Moreover, EBRT segment is also anticipated to maintain its dominance during the forecast period
  • North America dominated the global market in 2022 owing to the factors such as the increase in new cancer cases, high awareness among healthcare professionals about advanced radiotherapy, and better healthcare access in the region

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline:
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Market Definitions
  • 3.3 Key Opportunities Prioritized
  • 3.4 Market Dynamic Analysis
    • 3.4.1 Rising Adoption Of Radiotherapy
    • 3.4.2 Technological Advancements In Radiotherapy
    • 3.4.3 Rising Prevalence Of Cancer
    • 3.4.4 Increase In Healthcare Expenditure
    • 3.4.5 Increasing APPLICATION OF Radiopharmaceuticals
  • 3.5 Market Restraint Analysis
    • 3.5.1 Lack Of Skilled Radiotherapy Professionals
    • 3.5.2 Inadequate Radiation Infrastructure
    • 3.5.3 Adverse Effects Of Radiotherapy
  • 3.6 Business Environment Analysis
    • 3.6.1 SWOT Analysis; By Factor (POLITICAL & LEGAL, Economic And Technological)
    • 3.6.2 Porter's Five Forces Analysis

Chapter 4 Radiation Oncology Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1 Radiation Oncology Market: Type Movement Analysis
  • 4.2 External Beam Radiation Therapy
    • 4.2.1 External Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
    • 4.2.2 Electron-Emitting High Energy Linear Accelerators
      • 4.2.2.1 Electron-Emitting High Energy Linear Accelerators Market, 2018 - 2030 (USD Million)
    • 4.2.3 Compact Advanced Radiotherapy Systems
      • 4.2.3.1 Compact Advanced Radiotherapy Systems Market, 2018 - 2030 (USD Million)
      • 4.2.3.2 Cyberknife
      • 4.2.3.2.1 Cyberknife Market, 2018 - 2030 (USD Million)
      • 4.2.3.3 Gamma Knife
      • 4.2.3.3.1 Gamma Knife Market, 2018 - 2030 (USD Million)
      • 4.2.3.4 Tomotherapy
      • 4.2.3.4.1 Tomotherapy Compact Market, 2018 - 2030 (USD Million)
    • 4.2.4 Proton Therapy
      • 4.2.4.1 Proton Therapy Market, 2018 - 2030 (USD Million)
      • 4.2.4.2 Cyclotron
      • 4.2.4.2.1 Cyclotron Market, 2018 - 2030 (USD Million)
      • 4.2.4.3 Synchrotron
      • 4.2.4.3.1 Synchrotron Market, 2018 - 2030 (USD Million)
  • 4.3 Internal Beam Radiation Therapy
    • 4.3.1 Internal Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
    • 4.3.2 Brachytherapy
      • 4.3.2.1 Brachytherapy Market, 2018 - 2030 (USD Million)
      • 4.3.2.2 Seeds
      • 4.3.2.2.1 Seeds Market, 2018 - 2030 (USD Million)
      • 4.3.2.3 Applicators And After-Loaders
      • 4.3.2.3.1 Applicators And After-Loaders Market, 2018 - 2030 (USD Million)
      • 4.3.2.4 Electronic Brachytherapy
      • 4.3.2.4.1 Electronic Brachytherapy Market, 2018 - 2030 (USD Million)
    • 4.3.3 Systemic Beam Radiation Therapy
      • 4.3.3.1 Systemic Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
    • 4.3.4 Others
      • 4.3.4.1 Others Market, 2016-2028 (USD Million)

Chapter 5 Radiation Oncology Market - Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 5.1 Radiation Oncology Market: Technology Movement Analysis
  • 5.2 External Beam Radiation Therapy (EBRT)
    • 5.2.1 EBRT Market, 2018 - 2030 (USD Million)
    • 5.2.2 Image-Guided Radiation Therapy (IGRT)
      • 5.2.2.1 IGRT Market, 2018 - 2030 (USD Million)
    • 5.2.3 Intensity Modulated Radiotherapy (IMRT)
      • 5.2.3.1 IMRT Market, 2018 - 2030 (USD Million)
    • 5.2.4 Stereotactic Radiotherapy
      • 5.2.4.1 Stereotactic Radiotherapy Market, 2018 - 2030 (USD Million)
    • 5.2.5 Proton Beam Therapy
      • 5.2.5.1 Proton Beam Therapy Market, 2018 - 2030 (USD Million)
    • 5.2.6 3D Conformal Radiotherapy (3D-CRT)
      • 5.2.6.1 3D-CRT Market, 2018 - 2030 (USD Million)
    • 5.2.7 Volumetric Modulated Arc Therapy (VMAT)
      • 5.2.7.1 VMAT Market, 2018 - 2030 (USD Million)
  • 5.3 Brachytherapy
    • 5.3.1 Brachytherapy Market, 2018 - 2030 (USD Million)
    • 5.3.2 Low Dose Rate (LDR) Brachytherapy
      • 5.3.2.1 LDR Brachytherapy Market, 2018 - 2030 (USD Million)
    • 5.3.3 High Dose Rate (HDR) Brachytherapy
      • 5.3.3.1 HDR Brachytherapy Market, 2018 - 2030 (USD Million)

Chapter 6 Radiation Oncology Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 Radiation Oncology Market: Application Movement Analysis
  • 6.2 External Beam Radiation Therapy (EBRT)
    • 6.2.1 Prostate Cancer
      • 6.2.1.1 Prostate Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.2 Breast Cancer
      • 6.2.2.1 Breast Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.3 Lung Cancer
      • 6.2.3.1 Lung Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.4 Head And Neck Cancer
      • 6.2.4.1 Head And Neck Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.5 Colorectal Cancer
      • 6.2.5.1 Colorectal Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.6 Others
      • 6.2.6.1 Others Market, 2018 - 2030 (USD Million)
  • 6.3 Internal Beam Radiation Therapy
    • 6.3.1 Prostate Cancer
      • 6.3.1.1 Prostate Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.2 Gynecologic Cancer
      • 6.3.2.1 Gynecologic Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.3 Breast Cancer
      • 6.3.3.1 Breast Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.4 Cervical Cancer
      • 6.3.4.1 Cervical Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.5 Penile Cancer
      • 6.3.5.1 Penile Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.6 Others
      • 6.3.6.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Radiation Oncology Market - Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 North America
    • 7.2.1 North America, SWOT Analysis
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.2.2 Key Country Dynamics
      • 7.2.2.3 Target Disease Prevalence
      • 7.2.2.4 Competitive Scenario
      • 7.2.2.5 Regulatory Framework
      • 7.2.2.6 Reimbursement Scenario
    • 7.2.3 Canada
      • 7.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.3.2 Key Country Dynamics
      • 7.2.3.3 Target Disease Prevalence
      • 7.2.3.4 Competitive Scenario
      • 7.2.3.5 Regulatory Framework
      • 7.2.3.6 Reimbursement Scenario
  • 7.3 Europe
    • 7.3.1 Europe, SWOT Analysis
    • 7.3.2 U.K.
      • 7.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.2 Key Country Dynamics
      • 7.3.2.3 Target Disease Prevalence
      • 7.3.2.4 Competitive Scenario
      • 7.3.2.5 Regulatory Framework
      • 7.3.2.6 Reimbursement Scenario
    • 7.3.3 Germany
      • 7.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.2 Key Country Dynamics
      • 7.3.3.3 Target Disease Prevalence
      • 7.3.3.4 Competitive Scenario
      • 7.3.3.5 Regulatory Framework
      • 7.3.3.6 Reimbursement Scenario
    • 7.3.4 France
      • 7.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.4.2 Key Country Dynamics
      • 7.3.4.3 Target Disease Prevalence
      • 7.3.4.4 Competitive Scenario
      • 7.3.4.5 Regulatory Framework
      • 7.3.4.6 Reimbursement Scenario
    • 7.3.5 Italy
      • 7.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.5.2 Key Country Dynamics
      • 7.3.5.3 Target Disease Prevalence
      • 7.3.5.4 Competitive Scenario
      • 7.3.5.5 Regulatory Framework
      • 7.3.5.6 Reimbursement Scenario
    • 7.3.6 Spain
      • 7.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.6.2 Key Country Dynamics
      • 7.3.6.3 Target Disease Prevalence
      • 7.3.6.4 Competitive Scenario
      • 7.3.6.5 Regulatory Framework
      • 7.3.6.6 Reimbursement Scenario
    • 7.3.7 Sweden
      • 7.3.7.1 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.7.2 Key Country Dynamics
      • 7.3.7.3 Target Disease Prevalence
      • 7.3.7.4 Competitive Scenario
      • 7.3.7.5 Regulatory Framework
      • 7.3.7.6 Reimbursement Scenario
    • 7.3.8 Denmark
      • 7.3.8.1 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.8.2 Key Country Dynamics
      • 7.3.8.3 Target Disease Prevalence
      • 7.3.8.4 Competitive Scenario
      • 7.3.8.5 Regulatory Framework
      • 7.3.8.6 Reimbursement Scenario
    • 7.3.9 Norway
      • 7.3.9.1 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.9.2 Key Country Dynamics
      • 7.3.9.3 Target Disease Prevalence
      • 7.3.9.4 Competitive Scenario
      • 7.3.9.5 Regulatory Framework
      • 7.3.9.6 Reimbursement Scenario
    • 7.3.10 Rest Of Europe
      • 7.3.10.1 Rest Of Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific, SWOT Analysis
    • 7.4.2 India
      • 7.4.2.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.2.2 Key Country Dynamics
      • 7.4.2.3 Target Disease Prevalence
      • 7.4.2.4 Competitive Scenario
      • 7.4.2.5 Regulatory Framework
      • 7.4.2.6 Reimbursement Scenario
    • 7.4.3 China
      • 7.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.3.2 Key Country Dynamics
      • 7.4.3.3 Target Disease Prevalence
      • 7.4.3.4 Competitive Scenario
      • 7.4.3.5 Regulatory Framework
      • 7.4.3.6 Reimbursement Scenario
    • 7.4.4 Japan
      • 7.4.4.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.4.2 Key Country Dynamics
      • 7.4.4.3 Target Disease Prevalence
      • 7.4.4.4 Competitive Scenario
      • 7.4.4.5 Regulatory Framework
      • 7.4.4.6 Reimbursement Scenario
    • 7.4.5 Australia
      • 7.4.5.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.5.2 Key Country Dynamics
      • 7.4.5.3 Target Disease Prevalence
      • 7.4.5.4 Competitive Scenario
      • 7.4.5.5 Regulatory Framework
      • 7.4.5.6 Reimbursement Scenario
    • 7.4.6 South Korea
      • 7.4.6.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.6.2 Key Country Dynamics
      • 7.4.6.3 Target Disease Prevalence
      • 7.4.6.4 Competitive Scenario
      • 7.4.6.5 Regulatory Framework
      • 7.4.6.6 Reimbursement Scenario
    • 7.4.7 THAILAND
      • 7.4.7.1 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.7.2 Key Country Dynamics
      • 7.4.7.3 Target Disease Prevalence
      • 7.4.7.4 Competitive Scenario
      • 7.4.7.5 Regulatory Framework
      • 7.4.7.6 Reimbursement Scenario
    • 7.4.8 Rest Of APAC
      • 7.4.8.1 Rest Of APAC Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America, SWOT Analysis
    • 7.5.2 Mexico
      • 7.5.2.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.5.2.2 Key Country Dynamics
      • 7.5.2.3 Target Disease Prevalence
      • 7.5.2.4 Competitive Scenario
      • 7.5.2.5 Regulatory Framework
      • 7.5.2.6 Reimbursement Scenario
    • 7.5.3 Brazil
      • 7.5.3.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.5.3.2 Key Country Dynamics
      • 7.5.3.3 Target Disease Prevalence
      • 7.5.3.4 Competitive Scenario
      • 7.5.3.5 Regulatory Framework
      • 7.5.3.6 Reimbursement Scenario
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.5.4.2 Key Country Dynamics
      • 7.5.4.3 Target Disease Prevalence
      • 7.5.4.4 Competitive Scenario
      • 7.5.4.5 Regulatory Framework
      • 7.5.4.6 Reimbursement Scenario
    • 7.5.5 Rest Of LATAM
      • 7.5.5.1 Rest Of LATAM Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 Middle East & Africa, SWOT Analysis
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.2.2 Key Country Dynamics
      • 7.6.2.3 Target Disease Prevalence
      • 7.6.2.4 Competitive Scenario
      • 7.6.2.5 Regulatory Framework
      • 7.6.2.6 Reimbursement Scenario
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.3.2 Key Country Dynamics
      • 7.6.3.3 Target Disease Prevalence
      • 7.6.3.4 Competitive Scenario
      • 7.6.3.5 Regulatory Framework
      • 7.6.3.6 Reimbursement Scenario
    • 7.6.4 UAE
      • 7.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.4.2 Key Country Dynamics
      • 7.6.4.3 Target Disease Prevalence
      • 7.6.4.4 Competitive Scenario
      • 7.6.4.5 Regulatory Framework
      • 7.6.4.6 Reimbursement Scenario
    • 7.6.5 Kuwait
      • 7.6.5.1 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.5.2 Key Country Dynamics
      • 7.6.5.3 Target Disease Prevalence
      • 7.6.5.4 Competitive Scenario
      • 7.6.5.5 Regulatory Framework
      • 7.6.5.6 Reimbursement Scenario
    • 7.6.6 Rest Of MEA
      • 7.6.6.1 Rest Of MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Public Companies
    • 8.1.1 Company Market Position Analysis
    • 8.1.2 Competitive Dashboard Analysis
    • 8.1.3 Strategic Framework
  • 8.2 Private Companies
    • 8.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 8.2.2 Regional Network Map
  • 8.3 Company Profiles
    • 8.3.1 Varian Medical Systems, Inc. (A Part Of Siemens Healthineers)
      • 8.3.1.1 Company Overview
      • 8.3.1.2 Financial Performance
      • 8.3.1.3 Product Benchmarking
      • 8.3.1.4 Strategic Initiatives
    • 8.3.2 Elekta AB
      • 8.3.2.1 Company Overview
      • 8.3.2.2 Financial Performance
      • 8.3.2.3 Product Benchmarking
      • 8.3.2.4 Strategic Initiatives
    • 8.3.3 Accuray Incorporated
      • 8.3.3.1 Company Overview
      • 8.3.3.2 Financial Performance
      • 8.3.3.3 Product Benchmarking
      • 8.3.3.4 Strategic Initiatives
    • 8.3.4 Ion Beam Applications (IBA).
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Financial Performance
      • 8.3.4.3 Product Benchmarking
      • 8.3.4.4 Strategic Initiatives
    • 8.3.5 BD (Becton, Dickinson And Company)
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Financial Performance
      • 8.3.5.3 Product Benchmarking
      • 8.3.5.4 Strategic Initiatives
    • 8.3.6 Isoray Medical
      • 8.3.6.1 Company Overview
      • 8.3.6.2 Financial Performance
      • 8.3.6.3 Product Benchmarking
      • 8.3.6.4 Strategic Initiatives
    • 8.3.7 Mevion Medical Systems
      • 8.3.7.1 Company Overview
      • 8.3.7.2 Product Benchmarking
      • 8.3.7.3 Strategic Initiatives
    • 8.3.8 Nordion Inc.
      • 8.3.8.1 Company Overview
      • 8.3.8.2 Product Benchmarking
      • 8.3.8.3 Strategic Initiatives
    • 8.3.9 NTP Radioisotopes SOC Ltd.
      • 8.3.9.1 Company Overview
      • 8.3.9.2 Financial Performance
      • 8.3.9.3 Product Benchmarking
      • 8.3.9.4 Strategic Initiatives
    • 8.3.10 Curium
      • 8.3.10.1 Company Overview
      • 8.3.10.2 Product Benchmarking
      • 8.3.10.3 Strategic Initiatives
    • 8.3.11 VIEWRAY TECHNOLOGIES, INC.
      • 8.3.11.1 Company Overview
      • 8.3.11.2 Financial Performance
      • 8.3.11.3 Product Benchmarking
      • 8.3.11.4 Strategic Initiatives